MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-13-2026
Aziyo Biologics Total Current Liabilities 2011-2026 | AZYO
Annual Total Current Liabilities Aziyo Biologics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.1 M | 37.8 M | 43 M | 42.6 M | 26 M | 26.8 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 43 M | 25.1 M | 33.6 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
219 M | $ 11.52 | -1.96 % | $ 1.73 B |  USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 9.23 | 2.73 % | $ 331 M | USA |
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
1.88 M | $ 2.15 | 6.97 % | $ 1.31 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 9.26 | -2.94 % | $ 713 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
Inogen
INGN
|
63.5 M | $ 6.33 | 0.16 % | $ 168 M | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
InMode Ltd.
INMD
|
70.7 M | $ 13.68 | -0.15 % | $ 884 M |  Israel |
 |
IRadimed Corporation
IRMD
|
10.2 M | $ 101.26 | 0.29 % | $ 1.29 B | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
AxoGen
AXGN
|
23.6 M | $ 33.16 | 1.69 % | $ 1.53 B | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 36.21 | -0.96 % | $ 1.12 B | USA |
 |
LivaNova PLC
LIVN
|
808 M | $ 61.97 | -0.69 % | $ 3.38 B |  Britain |
 |
LENSAR
LNSR
|
15 M | $ 5.57 | 0.18 % | $ 64.2 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | Israel |
 |
NanoVibronix
NAOV
|
2.72 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
10.5 M | $ 24.44 | -1.05 % | $ 207 M | USA |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
Medtronic PLC
MDT
|
12.9 B | $ 86.79 | 0.24 % | $ 112 B | USA |
 |
MiMedx Group
MDXG
|
64.3 M | $ 4.12 | -0.36 % | $ 609 M | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.67 | -3.31 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
1.9 M | $ 2.31 | 6.94 % | $ 3.61 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
InspireMD
NSPR
|
10.7 M | $ 1.79 | 1.13 % | $ 115 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
712 M | $ 11.43 | -0.44 % | $ 1.54 B | USA |
 |
Orthofix Medical
OFIX
|
170 M | $ 11.74 | 0.17 % | $ 465 M |  Curacao |
 |
Myomo
MYO
|
8.35 M | $ 0.7 | 0.44 % | $ 29.3 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
14 M | $ 2.32 | -3.33 % | $ 136 M | Israel |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.7 | -5.37 % | $ 138 M |  France |
 |
Penumbra
PEN
|
183 M | $ 335.38 | 0.36 % | $ 13.1 B | USA |
 |
Quanterix Corporation
QTRX
|
74.8 M | $ 4.01 | 4.97 % | $ 171 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 16.12 | 1.32 % | $ 378 M | USA |
 |
Outset Medical
OM
|
37.6 M | $ 3.44 | -2.55 % | $ 52.3 K | USA |